What many dont know: a higher-dose version of semaglutide called Wegovy was specifically approved for weight loss in 2021 its essentially the same active compound found in Ozempic
GLP-1 receptor agonists are recognized for their weight-loss promoting effects through appetite suppression, delayed gastric emptying, and enhanced satiety
Notices have been issued to those found breaking the rules. Businesses that violate regulations will face license cancellation, fines, and legal action
However, there are limited data whether any therapy is effective in patients with NASH cirrhosis, Rohit Loomba, MD, MHSc , director of hepatology and the NAFLD Research Center and vice chief of gastroenterology at the University of California, San Diego, told Healio